Baclofen Dosing for Spasticity in Adults
Start baclofen at 5 mg three times daily and increase by 5 mg per dose every 3 days until optimal effect is achieved, typically between 40-80 mg daily, with a maximum of 80 mg daily (20 mg four times daily). 1
Starting Dose and Titration Schedule
The FDA-approved dosing regimen follows a structured escalation:
- Days 1-3: 5 mg three times daily (15 mg/day total)
- Days 4-6: 10 mg three times daily (30 mg/day total)
- Days 7-9: 15 mg three times daily (45 mg/day total)
- Days 10-12: 20 mg three times daily (60 mg/day total)
- Beyond day 12: Additional increases may be necessary but should not exceed 80 mg/day 1
Target and Maximum Doses
The optimal therapeutic dose typically falls between 40-80 mg daily, divided into multiple doses throughout the day. The absolute maximum is 80 mg daily (20 mg four times daily) 1. Once you identify the lowest dose that provides optimal response, maintain that dose rather than continuing escalation.
Critical Safety Considerations
Abrupt Withdrawal Risk
Never discontinue baclofen abruptly. Hallucinations and seizures have occurred with sudden withdrawal 1. If discontinuation is necessary (except for serious adverse reactions), taper the dose slowly 1.
Renal Impairment
Baclofen is primarily excreted unchanged through the kidneys, so reduce dosage in patients with impaired renal function 1. Start with lower doses and titrate more cautiously in this population.
Pregnancy Considerations
Baclofen increases the risk of omphaloceles and skeletal abnormalities in animal studies at doses 7-13 times the maximum human dose. If used during pregnancy, gradually reduce and discontinue before delivery to prevent neonatal withdrawal symptoms (increased muscle tone, tremor, jitteriness, seizures) 1.
Common Pitfalls
- Inadequate trial duration: Patients require sufficient time at each dose level to assess response before escalating
- Exceeding maximum dose: The 80 mg/day limit is absolute for oral baclofen in spasticity
- Rapid discontinuation: Always taper slowly to avoid withdrawal seizures
- Ignoring renal function: Failure to adjust for kidney impairment increases toxicity risk
Alternative Context: Alcohol Use Disorder
While the evidence provided includes studies on baclofen for alcohol use disorder, this is off-label use with inconsistent efficacy data. The doses studied ranged from 30-300 mg/day 2, 3, 4, far exceeding the FDA-approved maximum for spasticity. High-dose baclofen (>100 mg/day) for alcohol dependence showed frequent adverse events and no clear benefit in the highest quality trial 4. This off-label indication requires specialized monitoring and should not be confused with standard spasticity dosing.